Tackling the Poor Sleep Pandemic: FRENZ Brainband by Earable Neuroscience Announces Global Sales After CES 2024 Innovation Award Win
FRENZ Brainband, a pioneering AI-powered sleep wearable initially introduced as a prototype at CES 2023, is now available for global delivery, heralding a new era in sleep tech and digital therapeutics for home use. FRENZ was early funded by Founders Fund and Samsung Ventures. BOULDER, Colo., Jan. 1
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Blue Ridge Bankshares, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – BRBS
NEW YORK, Jan. 14, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Blue Ridge Bankshares, Inc. (NYSE American: BRBS) between March 10, 2023 and October 31, 2023, both dates inclusive (the “Class Period”), of the im
Celebrity Judges and Hosts Announced for the 2024 Miss America Competition
ORLANDO, Fla., Jan. 14, 2024 /PRNewswire/ — The Miss America Opportunity is proud to announce its esteemed panel of celebrity judges for the 2024 Miss America competition to be held in Orlando, Florida on Sunday, January 14. These extraordinary individuals will be tasked with selecting the nex
National Press Club Statement On Iranian Journalists Release From Prison
WASHINGTON, Jan. 14, 2024 /PRNewswire/ — Following is a statement from Eileen O’Reilly, president of the National Press Club and Gil Klein, president of the National Press Club Journalism Institute on the release of Iranian journalists Niloofar Hamedi and Elaheh Mohammadi earlier today f
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Mobileye Global Inc. – MBLY
NEW YORK, Jan. 14, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Mobileye Global Inc. (“Mobileye” or the “Company”) (NASDAQ: MBLY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Milestone Pharmaceuticals Inc.- MIST
NEW YORK, Jan. 14, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Milestone Pharmaceuticals Inc. (“Milestone” or the “Company”) (NASDAQ: MIST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Envoy Medical, Inc.- COCH
NEW YORK, Jan. 14, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Envoy Medical, Inc. (“Envoy” or the “Company”) (NASDAQ: COCH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
